Ahmed Kotb/daiichisankyo.us
Jul 18, 2026, 20:15
Ahmed Kotb: Exploring Qualitative Platelet Defects
Ahmed Kotb, Head of Global Oncology Medical Affairs at Daiichi Sankyo, shared a post on X:
“Qualitative Platelet Defects
Inherited
- Glanzmann: low GPIIb/IIIa – No aggregation except ristocetin
- Bernard–Soulier: low GPIb – Abnormal ristocetin
- Storage pool disease: Absent 2ry wave
Acquired
- Drugs:Aspirin, Clopidogrel, GP IIb/IIIa inhibitor
- Diseases: Uremia, liver disease”
Stay updated with Hemostasis Today.
-
Jul 19, 2026, 08:35Eugene Fan: A Rewarding Few Days at the ISTH 2026 Congress in Paris
-
Jul 19, 2026, 08:27Endothelial VTE, Immunotherapy Resistance and Survival Across Cancers – JTH
-
Jul 19, 2026, 08:20Patrick Vickers: My New Contribution to Hyper Acute Stroke Nursing Research
-
Jul 19, 2026, 08:13Jan van der Merwe: Meet the Inspiring Doctors Behind the Angels Stroke Heroes Podcast
-
Jul 19, 2026, 07:47Brian O Mahony: Conclusions on Use of Low Dose Emicizumab by Patil ISTH 2026
-
Jul 19, 2026, 07:43Zain Iqbal: Science Alone Is Not Enough – Moving Anticoagulation Forward After ISTH 2026
-
Jul 19, 2026, 07:37The Unanswered Questions of Extravascular FIX – CRH French Reference Center for Hemophilia Lyon
-
Jul 19, 2026, 07:29Jessica Garcia: Honored to Join the RareAF Podcast During the Texas Bleeding Disorders Conference
-
Jul 19, 2026, 07:23Caitlin Raymond: The Unmeasured Risks of Consecutive Daily TPE